Similar long-term cardiovascular effects of propofol or isoflurane anesthesia during ischemia/reperfusion in dogs

Canadian Journal of Anesthesia

Volumn 49, Issue 9, 2002, Pages 978-985

  Thompson, Kerry ^a,b   Wisenberg, Gerald ^a,b,c   Sykes, Jane ^a   Thompson, R Terry ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; GADOLINIUM PENTETATE; GLIBENCLAMIDE; ISOFLURANE; PHOSPHORUS; POTASSIUM CHANNEL BLOCKING AGENT; PROPOFOL; PROTON; RADIOACTIVE MICROSPHERE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CELL PH; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY REPERFUSION; DOG; DRUG EFFECT; FEMALE; GENERAL ANESTHESIA; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HEMODYNAMIC MONITORING; HIGH ENERGY PHOSPHATE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0036872189     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016887     Document Type: Article

References (37)

1. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC. Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology 1997; 86: 1128-39.
2. ATP channels. Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997; 87: 361-70.
3. Piriou V, Chiari P, Knezynski S, et al. Prevention of isoflurane-induced preconditioning by 5- hydroxyde-canoate and gadolinium. Possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. Anesthesiology 2000, 93: 756-64.
4. Boutros A, Wang J, Capuano C. Isoflurane and halothane increase adenosine triphosphate preservation, but do not provide additive recovery of function after ischemia, in preconditioned rat hearts. Anesthesiology 1997; 86: 109-17.
5. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999; 91: 521-30.
6. + channel abolishes the anti-ischemic effects of isoflurane in dog hearts. Acta Anaesthesiol Scand 1997; 41: 531-5.
7. Cason BA, Gamperl AK, Slocum RE, Hickey RF. Anesthetic-induced preconditioning. Previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997; 87: 1182-90.
8. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997; 86: 699-709.
9. Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RF, Cason BA. Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. Anesthesiology 1999; 90: 812-21.
10. Ismaeil MS, Tkachenko I, Hickey RF, Cason BA. Colchicine inhibits isoflurane-induced preconditioning. Anesthesiology 1999; 91: 1816-22.
11. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81: 905-12.
12. Mattheussen M, Rusy BF, Van Aken H, Flameng W. Recovery of function and adenosine triphosphate metabolism following myocardial ischemia induced in the presence of volatile anesthetics. Anesth Analg 1993; 76: 69-75.
13. Javadov SA, Lim KHH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45: 360-9.
14. Halestrap AP, Kerr PM, Javadov S, Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1998; 1366: 79-94.
15. Ko SH, Yu CW, Lee SK, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg 1997; 85: 719-24.
16. Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 1998; 86: 252-8.
17. Yoo KY, Yang SY, Lee J, et al. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth 1999; 82: 90-6.
18. Ebel D, Schlack W, Comfere T, Preckel B, Thamer V. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth 1999; 83: 903-8.
19. Ross S, Munoz H, Piriou V, Ryder WA, Foex P. A comparison of the effects of fentanyl and propofol on left ventricular contractility during myocardial stunning. Acta Anaesthesiol Scand 1998; 42: 23-31.
20. Campbell CM, Wisenberg G, Sykes J, Thompson RT. Controlled reperfusion after myocardial ischemia in a canine model monitored by two-dimensional phosphorus 31 chemical shift spectroscopic imaging. Am Heart J 1997; 133: 508-16.
21. 31P chemical shift imaging. Biochem Cell Biol 1998; 76: 522-31.
22. Nolan A, Reid J. Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery. Br J Anaesth 1993; 70: 546-51.
23. 31P chemical shift spectroscopic imaging. Magn Reson Med 1997; 38: 577-84.
24. 31P brain spectra. NMR Biomed 1999; 12: 8-14.
25. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996; 36: 684-93.
26. Pereira RS, Prato FS, Lekx KS, Sykes J, Wisenberg G. Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion. Magn Reson Med 2000; 44: 309-16.
27. Thornhill RE, Prato FS, Pereira RS, Wisenberg G, Sykes J. Examining a canine model of stunned myocardium with Gd-DTPA-enhanced MRI. Magn Reson Med 2001; 45: 864-71.
28. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
29. Silverman J, Muir III WW. A review of laboratory animal anesthesia with chloral hydrate and chloralose. Lab Anim Sci 1993; 43: 210-6.
30. Turner DM, Ilkiw JE. Cardiovascular and respiratory effects of three rapidly acting barbiturates in dogs. Am J Vet Res 1990; 51: 598-604.
31. ATP, channel linked mechanisms in rats. Br J Anaesth 2000; 84: 204-14.
32. Schultz JEJ, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89: 123-37.
33. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91: 1327-32.
34. Short CE, Bufalari A. Propofol anesthesia. Vet Clin North Am Small Anim Pract 1999; 29: 747-78.
35. Bryson HM, Fulton BR, Faulds D. Propofol. An update of its use in anaesthesia and conscious sedation. Drugs 1995; 50: 513-59.
36. Ansley DM, Sun J, Visser WA, et al. High dose propofol enhances red cell antioxidant capacity during CPB in humans. Can J Anesth 1999; 46: 641-8.
37. Piper HM, Garia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998; 38: 291-300.